CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement

Leuk Lymphoma. 2009 Oct;50(10):1715-7. doi: 10.1080/10428190903191866.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • CD56 Antigen / analysis*
  • Connective Tissue Diseases / diagnosis
  • Cyclophosphamide / administration & dosage
  • Diagnostic Errors
  • Doxorubicin / administration & dosage
  • Epstein-Barr Virus Infections / diagnosis
  • Epstein-Barr Virus Infections / drug therapy
  • Epstein-Barr Virus Infections / pathology*
  • Eyelid Neoplasms / pathology*
  • Fatal Outcome
  • Female
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Immunophenotyping
  • Killer Cells, Natural / chemistry
  • Killer Cells, Natural / pathology*
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / pathology*
  • Lymphoma, Non-Hodgkin / virology
  • Lymphoma, T-Cell, Cutaneous / diagnosis
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Lymphoma, T-Cell, Cutaneous / pathology*
  • Lymphoma, T-Cell, Cutaneous / virology
  • Male
  • Nose
  • Prednisolone / administration & dosage
  • Skin / pathology*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / virology
  • T-Lymphocyte Subsets / chemistry
  • T-Lymphocyte Subsets / pathology*
  • T-Lymphocyte Subsets / virology
  • Vincristine / administration & dosage
  • Young Adult

Substances

  • CD56 Antigen
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • VAP-cyclo protocol